Ancient grain, modern hope: foxtail millet muffins may tame blood sugar in obesity
NCT ID NCT07699250
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study investigates whether adding foxtail millet muffins to the diet can help manage blood sugar and improve metabolic health in obese adults with type 2 diabetes. Over 10 weeks, participants eat either a wheat muffin or one or two foxtail millet muffins daily, alongside a low glycemic index diet. Researchers track changes in weight, blood sugar, cholesterol, and liver function to see if this simple dietary swap makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Foxtail millet muffin
- What this could lead to
- If effective, this dietary approach could offer a simple, affordable way for obese diabetic patients to improve blood sugar control and reduce heart disease risk.
- What could go wrong
- This is a small, short-term dietary study. Results may not apply to all diabetics, and long-term benefits or risks are unknown. Dietary changes alone may not be enough for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sana Noreen
Lahore, Punjab Province, 54000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- Could the speed of blood sugar drop harm the eyes? a study puts it to the test.
- Could a silent nerve problem mask deadly heart risks in sleep apnea patients?